At 3.4% CAGR, Allergic Rhinitis Treatment Market Size Worth $16.3 Billion by 2027: IndustryARC

[ad_1]

Market Research Reports, Business Advisory Services and Analytics

Growing applications of immunotherapy for allergic rhinitis are expected to drive the growth of the allergic rhinitis treatment market

HYDERABAD, TELANGANA, INDIA, Sept. 27, 2022 /EINPresswire.com/ — IndustryARC in its latest report predicts the allergic rhinitis treatment market size to reach $16.3 billion by 2027, with a CAGR of 3.4% over the forecast period 2022-2027. Treatment for allergic rhinitis, as the most effective treatment, involves recognizing and avoiding the allergens that cause the symptoms. If it is not completely preventable, steps should be taken to reduce exposure. Antihistamines, decongestants, corticosteroids, and immunotherapy are treatment options for curing allergic rhinitis. Pharmacological alternatives for the treatment of allergic rhinitis involve intranasal corticosteroids, oral and intranasal antihistamines, decongestants, intranasal cromolyn, intranasal anticholinergics, and leukotriene receptor antagonists. If there is a particularly severe episode of symptoms and accelerated relief is needed, a brief course of corticosteroid tablets lasting 5-10 days may be prescribed. The report offers a comprehensive analysis of the market, its main segments, growth factors, trends, drivers and challengers, key players and more.

Click here to browse the full summary of the report:
https://www.industryarc.com/Report/15389/allergic-rhinitis-market.html

Key points to remember:

1. Geographically, the North America allergic rhinitis treatment market accounted for the highest revenue share in 2021 and it is poised to dominate the market during 2022-2027 owing to the rapid advancements in treatment diseases involving antihistamines in the North American region.

2. The growth of the allergic rhinitis treatment market is driven by the increasing prevalence of allergic rhinitis caused by allergens such as grass, pollen, dust, dander, mold or animal saliva requiring the application of antihistamines. However, one of the major factors hindering the growth of the allergic rhinitis treatment market is the inadequate symptom relief in some patients offered by some first-line allergic rhinitis treatments currently considered in real life.

3. Huge patient pool further propels the growth of perennial allergic rhinitis segment. A detailed analysis of the Allergic Rhinitis Treatment Market on the strengths, weaknesses and opportunities of the key players operating in the market will be provided in the Allergic Rhinitis Treatment Market report. .

Want to know more about relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=15389

Segmental analysis:

1. Huge patient pool further propels the growth of perennial allergic rhinitis segment. The seasonal allergic rhinitis segment is expected to grow with the fastest CAGR of 3.7% during the forecast period 2022-2027 due to the growing prevalence of seasonal allergic rhinitis

2. The Allergic Rhinitis Treatment Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (allergic rhinitis treatment market) held the largest share with 35% of the overall market in 2021.

3. The Asia-Pacific region is estimated to be the region with the fastest CAGR rate during the forecast period 2022-2027. This growth is due to factors such as the growing ubiquity of allergic rhinitis requiring the application of antihistamines in the Asia-Pacific region.

4. The treatment-based allergic rhinitis treatment market can be segmented into antihistamines, corticosteroids, immunotherapy, decongestants and others. The antihistamines segment held the largest market share in 2021. This growth is driven by the increasing use of oral H1 antihistamines as first-line treatment for mild to moderate allergic rhinitis.

5. Corticosteroids segment is expected to grow with the fastest CAGR of 3.9% during the forecast period 2022-2027 owing to the increasing application of nasal corticosteroids used to relieve inflammation and itching being accessible in the form of sprays.

Competitive Landscape:

Top 5 Allergic Rhinitis Treatment Industry Players are-

1.Sanofi

2. Cigna

3. Himalayas

4. Johnson & Johnson

5. Merck

Click the following link to purchase the Allergic Rhinitis Treatment Market Report:
https://www.industryarc.com/reports/request-quote?id=15389

Why choose IndustryARC?

IndustryARC is one of the world’s leading market research and consulting companies. It produces over 500 unique market reports every year. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your favorite market report from the website, but also get personalized support on specific reports.

Related reports:

A. Perennial Allergic Rhinitis Market
https://www.industryarc.com/Report/15981/perennial-allergic-rhinitis-market.html

B. Allergic Conjunctivitis Market
https://www.industryarc.com/Report/15388/allergic-conjunctivitis-treatment-market.html

Contact us:
Mr Venkat Reddy
IndustryCRA
Email: [email protected], [email protected]
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062

Venkat Reddy
IndustryCRA
+1 614-588-8538
write to us here
Visit us on social media:
Facebook
Twitter
LinkedIn


[ad_2]Source link

About Chris Y. Camp

Check Also

FDA approves treatment that delays onset of type 1 diabetes

[ad_1] For the first time, the US Food and Drug Administration has “approved a treatment …